Telogen Effluvium, Beau's Lines, and Acral Peeling Associated with COVID-19 Infection

    June 2021 in “ JAAD Case Reports ”
    Junwen Deng, Tracy Ngo, Tian Hao Zhu, Caroline Halverstam
    Image
    Studysummary This article reviews the cutaneous manifestations of COVID-19, highlighting their potential as early indicators of infection, and reports no new clinical results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    A 41-year-old woman experienced telogen effluvium, Beau's lines, and acral peeling as a result of a COVID-19 infection. Initially presenting with COVID-19 symptoms in April 2020 but not tested for the virus, she later confirmed past infection through a COVID-19 IgG antibody test after noticing hair and skin changes two months post-symptoms. By August 2020, she developed Beau's lines, and by December 2020, her dermatological symptoms had improved or resolved without treatment, with no recurrence by April 2021. The document highlights the potential for COVID-19 to disrupt keratinocyte, hair follicle, and nail keratin growth, causing such dermatological issues, and underscores the significance of recognizing these cutaneous signs as potential sole indicators of COVID-19 infection.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results